Synchron pauses trial of its second-generation Stentrode brain implant
Synchron has paused clinical trials of its second-generation Stentrode device due to signal lead issues, while restructuring the company and...
Synchron has paused clinical trials of its second-generation Stentrode device due to signal lead issues, while restructuring the company and...
OpenAI has acquired Odessia, an AI travel assistant startup created by Sonder founder Francis Davidson, even though it has not...